Science Explorer Interactive view Map
Nonprofit · Edinburgh · United Kingdom

Myeloma UK

myeloma.org.ukROR OpenAlex
Research works
43
▲ 26% vs 2013–17
Citations
966
22.5 per fractional work
Top-10% rate
9.4%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: Myeloma UK is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.81× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.90× its world share, 0 worksImmunology and Micro…Chemistry: 0.36× its world share, 0 worksChemistryMaterials Science: 0.05× its world share, 0 worksMaterials ScienceHealth Professions: 0.34× its world share, 0 worksHealth ProfessionsMedicine: 3.78× its world share, 10 worksMedicineEconomics, Econometrics and Finance: 3.19× its world share, 1 worksEconomics, Econometr…Psychology: 1.16× its world share, 0 worksPsychologySocial Sciences: 0.38× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.

Which keywords describe research at Myeloma UK?

By fractional works in all years, weighted toward what it does more of than the world: Proteasome Inhibitors, Staging System, Diagnosis Criteria, International Myeloma Working Group, Quality of Life, Clinical Trials, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Proteasome Inhibitors12▲ 409×2 topics
  2. Staging System12▲ 450×2 topics
  3. Diagnosis Criteria12▲ 933×1 topic
  4. International Myeloma Working Group12▲ 933×1 topic
  5. Quality of Life3▲ 5.9×4 topics
  6. Clinical Trials3▲ 11×9 topics
  7. Chemotherapy-Induced Peripheral Neuropathy2▲ 108×1 topic
  8. Taxanes2▲ 108×1 topic
  9. Cancer2▲ 3.5×9 topics
  10. Mental Health2▲ 3.7×4 topics
  11. Diagnosis2▲ 3.7×4 topics
  12. Epidemiology2◆ 0.94×8 topics
  13. Cancer Therapy2▲ 5.5×5 topics
  14. Cost of Care2▲ 182×1 topic
  15. Financial Toxicity2▲ 182×1 topic
  16. Prognostic Factors2▲ 7.8×6 topics
  17. Trauma2▲ 18×2 topics
  18. Treatment2▲ 2.6×3 topics
  19. Inflammation1▲ 1.40×7 topics
  20. Immunotherapy1▲ 4.5×7 topics
  21. Community Engagement1▲ 9.5×2 topics
  22. Degenerative Disc Disease1▲ 32×2 topics
  23. Meta-Analysis1▲ 5.3×4 topics
  24. Physical Activity1▲ 7.3×2 topics
  25. Health Disparities1▲ 13×3 topics
  26. Neuroprotection1▲ 6.5×2 topics
  27. Prognosis1▲ 8.0×3 topics
  28. Extracurricular Activities1▲ 142×1 topic
  29. Immigrant1▲ 46×1 topic
  30. Refugee1▲ 59×1 topic
  31. Youth Development Programs1▲ 142×1 topic

Which research topics does Myeloma UK publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, Cervical and Thoracic Myelopathy, Cancer Treatment and Pharmacology and Testicular diseases and treatments.

Multiple Myeloma Researc…5Multiple Myeloma Research and Treatments: 5 fractional worksCervical and Thoracic Myelopathy: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksTesticular diseases and treatments: 0 fractional worksFamily Support in Illness: 0 fractional worksAmyloidosis: Diagnosis, Treatment, Outcomes: 0 fractional worksPerfectionism, Procrastination, Anxiety Studies: 0 fractional worksPharmaceutical Economics and Policy: 0 fractional worksCOVID-19 and healthcare impacts: 0 fractional worksCAR-T cell therapy research: 0 fractional works
HematologySurgeryOncologySociology and Political Science3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Multiple Myeloma Research and Treatments Hematology 5 works
  2. 2 Cervical and Thoracic Myelopathy Surgery 1 works
  3. 3 Cancer Treatment and Pharmacology Oncology 1 works
  4. 4 Testicular diseases and treatments Surgery 0 works
  5. 5 Family Support in Illness Sociology and Political Science 0 works
  6. 6 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 0 works
  7. 7 Perfectionism, Procrastination, Anxiety Studies Clinical Psychology 0 works
  8. 8 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  9. 9 COVID-19 and healthcare impacts Oncology 0 works
  10. 10 CAR-T cell therapy research Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.2%not open51.8%

World: 28% of research is openly available.

with international co-authors36.8%domestic only63.2%

World: 19% is written across borders.

How has Myeloma UK's research output changed?

Output in 2018–2022 was 26% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Edinburgh

All research institutions in Edinburgh

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.